Abstract View: 900
PDF Download: 356
Hypothesis
Colchicine; An inflammasome inhibitor and a potential therapy in severe COVID19?
Sara Bahadoram
1 
, Mohammad-Reza Mahmoudian-Sani
1 , Bijan Keikhaei
1 , Mohammad Bahadoram
1* , Amar Helalinasab
2 , Esma'il Akade
3 1 Thalassemia and Hemoglobinopathy Research Center, Research Institute of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2 Silk Clinics, Dubai Health Care City Dubai, United Arab Emirates.
3 Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Citation: Bahadoram S, Mahmoudian-Sani MR, Keikhaei B, Bahadoram M, Helalinasab A, Akade E. Colchicine; An inflammasome inhibitor and a potential therapy in severe COVID19? J Ren Endocrinol. 2022;8:e19065. doi: 10.34172/jre.2022.19065.
Abstract View: 901
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 49 | 65 | 58 | 53 | 42 | 31 | 27 | 22 | 29 | 20 | 4 | |
| 2023 | 36 | 28 | 29 | 36 | 31 | 42 | 37 | | | 40 | 68 | 43 |
| 2022 | | | | | | | | | | 20 | 53 | 38 |
PDF Download: 356
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 13 | 10 | 20 | 22 | 15 | 13 | 9 | 19 | 14 | 16 | 3 | |
| 2023 | 14 | 13 | 17 | 12 | 12 | 13 | 15 | 1 | | 6 | 16 | 12 |
| 2022 | | | | | | | | | | 7 | 37 | 27 |